Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study

被引:11
作者
Roetker, Nicholas S. [1 ,5 ]
Guo, Haifeng [1 ]
Ramey, Dena Rosen [2 ]
McMullan, Ciaran J. [2 ,4 ]
Atkins, G. Brandon [2 ]
Wetmore, James B. [1 ,3 ]
机构
[1] Hennepin Healthcare Res Inst, Chron Dis Res Grp, Minneapolis, MN USA
[2] Merck & Co Inc, Kenilworth, NJ USA
[3] Univ Minnesota, Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN USA
[4] Univ Minnesota, Dept Med, Minneapolis, MN USA
[5] Hennepin Healthcare Res Inst, Chron Dis Res Grp, 701 Pk Ave,Suite S2 100, Minneapolis, MN 55415 USA
关键词
CHRONIC DIALYSIS PATIENTS; CHRONIC KIDNEY-DISEASE; PULMONARY-EMBOLISM; ATRIAL-FIBRILLATION; MORTALITY; STROKE; OUTCOMES; AGENTS; TRENDS;
D O I
10.1016/j.xkme.2022.100456
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: The risks of major bleeding, thrombosis, and cardiovascular events are elevated in patients receiving maintenance hemodialysis (HD). Our objective was to compare the risk of these outcomes in HD according to the permanent vascular access type. Study Design: Observational cohort study. Setting & Participants: Using data from the United States Renal Data System (2010-2015), we included patients with kidney failure who were greater than 18 years, had Medicare as the primary payer, were not using an oral anticoagulant, and were newly using an arteriovenous (AV) access for HD. Exposure: AV graft (AVG) or AV fistula (AVF). Outcomes: Major bleeding, venous thromboembolism, ischemic stroke, myocardial infarction, cardiovascular death, and critical limb ischemia. Analytical Approach: Comparing 17,763 AVG and 60,329 AVF users, we estimated the 3-year incidence rates and incidence rate ratios (IRRs) of each outcome using Poisson regression. IRRs were adjusted for sociodemographic and clinical covariates. Results: The use of an AVG, compared with that of an AVF, was associated with an increased risk of venous thromboembolism (10.8 vs 5.3 events per 100 person-years; adjusted IRR, 1.74; 95% CI, 1.63-1.85) but not with the risk of major bleeding (IRR, 1.04; 95% CI, 0.93-1.17). The use of an AVG was also potentially associated with a slightly increased risk of cardiovascular death (IRR, 1.09; 95% CI, 1.01-1.16). Limitations: This analysis focused on patients with a functioning AV access; adverse events that may occur during access maturation should also be considered when selecting a vascular access. Conclusions: The use of an AVG, relative to an AVF, in HD is associated with an increased risk of venous thromboembolism. Given recent guidelines emphasizing selection of the "right access " for the "right patient, " the results of this study should potentially be considered as one additional factor when selecting the optimal access for HD.
引用
收藏
页数:10
相关论文
共 37 条
[1]   Burden of Readmissions Among Patients With Critical Limb Ischemia [J].
Agarwal, Shikhar ;
Pitcavage, James M. ;
Sud, Karan ;
Thakkar, Badal .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (15) :1897-1908
[2]   A Patient with Recurrent Arteriovenous Graft Thrombosis [J].
Allon, Michael .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (12) :2255-2262
[3]   Platelet dysfunction in renal failure [J].
Boccardo, P ;
Remuzzi, R ;
Galbusera, M .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (05) :579-589
[4]   Barriers to optimal vascular access for hemodialysis [J].
Brown, Robert S. .
SEMINARS IN DIALYSIS, 2020, 33 (06) :457-463
[5]   Pulmonary Embolism Following Thrombolysis of Dialysis Access: Is Anticoagulation Really Necessary? [J].
Calderon, Kellie ;
Jhaveri, Kenar D. ;
Mossey, Robert .
SEMINARS IN DIALYSIS, 2010, 23 (05) :522-524
[6]   Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform [J].
Chertow, Glenn M. ;
Liu, Jiannong ;
Monde, Keri L. ;
Gilbertson, David T. ;
Brookhart, M. Alan ;
Beaubrun, Anne C. ;
Winkelmayer, Wolfgang C. ;
Pollock, Allan ;
Herzog, Charles A. ;
Ashfaq, Akhtar ;
Sturmer, Til ;
Rothman, Kenneth J. ;
Bradbury, Brian D. ;
Collins, Allan J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (10) :3129-3138
[7]   Cardiovascular disease in dialysis patients [J].
Cozzolino, Mario ;
Mangano, Michela ;
Stucchi, Andrea ;
Ciceri, Paola ;
Conte, Ferruccio ;
Galassi, Andrea .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 :28-34
[8]   An automated database case definition for serious bleeding related to oral anticoagulant use [J].
Cunningham, Andrew ;
Stein, C. Michael ;
Chung, Cecilia P. ;
Daugherty, James R. ;
Smalley, Walter E. ;
Ray, Wayne A. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (06) :560-566
[9]   Vascular access hemorrhages contribute to deaths among hemodialysis patients [J].
Ellingson, Katherine D. ;
Palekar, Rakhee S. ;
Lucero, Cynthia A. ;
Kurkjian, Katherine M. ;
Chai, Shua J. ;
Schlossberg, Dana S. ;
Vincenti, Donna M. ;
Fink, Jeffrey C. ;
Davies-Cole, John O. ;
Magri, Julie M. ;
Arduino, Matthew J. ;
Patel, Priti R. .
KIDNEY INTERNATIONAL, 2012, 82 (06) :686-692
[10]   Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation [J].
Graham, David J. ;
Reichman, Marsha E. ;
Wernecke, Michael ;
Hsueh, Hui ;
Izem, Rima ;
Southworth, Mary Ross ;
Wei, Yuqin ;
Liao, Jiemin ;
Goulding, Margie R. ;
Mott, Katrina ;
Chillarige, Yoganand ;
MaCurdy, Thomas E. ;
Worrall, Chris ;
Kelman, Jeffrey A. .
JAMA INTERNAL MEDICINE, 2016, 176 (11) :1662-1671